|
Volumn 18, Issue 2, 2002, Pages 140-144
|
Pain reduction after laser in situ keratomileusis with ketorolac tromethamine ophthalmic solution 0.5%: A randomized, double-masked, placebo-controlled trial
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACULAR PF;
DEXTROPROPOXYPHENE NAPSILATE;
KETOROLAC TROMETAMOL;
PARACETAMOL;
PROXYMETACAINE;
ADULT;
ANALGESIC ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
FEMALE;
HUMAN;
KERATOMILEUSIS;
MALE;
MULTICENTER STUDY;
PAIN ASSESSMENT;
POSTOPERATIVE PAIN;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
WOUND HEALING;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASTIGMATISM;
CORNEA;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
KERATOMILEUSIS, LASER IN SITU;
KETOROLAC TROMETHAMINE;
MALE;
MIDDLE AGED;
MYOPIA;
OPHTHALMIC SOLUTIONS;
PAIN MEASUREMENT;
PAIN, POSTOPERATIVE;
|
EID: 0036300889
PISSN: 1081597X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (20)
|
References (18)
|